title: Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study.
abstract: OBJECTIVE
  The mortality rate from upper gastrointestinal bleeding (UGIB) remains high, at 5 % - 10 %. The aim of the current study was to describe the epidemiological characteristics, prognostic factors, and actual practice in a cohort of patients with UGIB admitted to French general hospitals.
  
  
  METHODS
  From March 2005 to February 2006, a prospective multicenter study was conducted at 53 French hospitals. A total of 3298 patients admitted for UGIB were enrolled consecutively. Patient data were collected up to the date of discharge from hospital.
  
  
  RESULTS
  Data were available for 2130 men and 1073 women (mean age 63 ± 18 years), one-third of whom were taking drugs that would increase the risk of UGIB. The two main causes of bleeding were peptic ulcers (38 %) and esophagogastric varices (EGV) or portal hypertensive gastropathy (24.5 %). Mean Rockall score was 5.0 ± 2.3. Endoscopy was performed on 96 % of patients (within 24 hours in 79 %), and 66 % of those with ulcers and 62.5 % of the EGV patients underwent hemostatic therapy when indicated. Rebleeding occurred in 9.9 % of the patients, and 8.3 % died. Independent predictors of rebleeding were: need for transfusion (odds ratio [OR] 19.1; 95 % confidence interval [95 %CI] 10.1 - 35.9); hemoglobin < 10 g/dL (OR: 1.7; 95 %CI 1.1 - 3.3); Rockall score (OR: 1.4 for each 1 point score increase; 95 %CI 1.0 - 1.9), systolic blood pressure < 100 mmHg (OR: 1.9; 95 %CI 1.4 - 2.5), and signs of recent bleeding (OR: 2.4; 95 %CI 1.7 - 3.5). Independent predictors of mortality were: Rockall score (OR: 2.8; 95 %CI 2.0 - 4.0), co-morbidities (OR: 3.6 for each additional co-morbidity; 95 %CI 2.0 - 6.3), and systolic blood pressure < 100 mmHg (OR: 2.1; 95 %CI 1.8 - 2.8). Rockall score, blood pressure and co-morbidities were taken as continuous variables meaning that the OR was 1.4 for every point increase, it was the same for blood pressure.
  
  
  CONCLUSIONS
  UGIB still occurs mainly as a result of peptic ulcers and portal hypertension in France, and causes significant rates of mortality. There is scope for improvement via better prevention (better use of UGIB-facilitating drugs), endoscopic therapy, and management of co-morbidities.
authors.affiliation: Service d'hepatogastroenterologie, Centre Hospitalier Montfermeil, Montfermeil, France. snahon@ch-montfermeil.fr
authors.forename: S
authors.initials: S
authors.lastname: Nahon
authors.forename: H
authors.initials: H
authors.lastname: Hagège
authors.forename: J P
authors.initials: JP
authors.lastname: Latrive
authors.forename: I
authors.initials: I
authors.lastname: Rosa
authors.forename: B
authors.initials: B
authors.lastname: Nalet
authors.forename: B
authors.initials: B
authors.lastname: Bour
authors.forename: R
authors.initials: R
authors.lastname: Faroux
authors.forename: P
authors.initials: P
authors.lastname: Gower
authors.forename: J P
authors.initials: JP
authors.lastname: Arpurt
authors.forename: J
authors.initials: J
authors.lastname: Denis
authors.forename: J
authors.initials: J
authors.lastname: Henrion
authors.forename: A J
authors.initials: AJ
authors.lastname: Rémy
authors.forename: A
authors.initials: A
authors.lastname: Pariente
mesh_terms: D000368:Aged; D004724:Endoscopy; D005260:Female; D005602:France / Q000453:epidemiology; D006471:Gastrointestinal Hemorrhage / Q000453:epidemiology* / Q000209:etiology / Q000401:mortality / Q000628:therapy; D016481:Helicobacter Infections / Q000150:complications; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011446:Prospective Studies; D016896:Treatment Outcome